Cardiovascular and Cardiometabolic Journal (CCJ)最新文献_第2页

A Late Prosthetic Mitral Valve Infective Endocarditis Caused by Micrococcus spp. that Fully Recovered by Antibiotics Treatment : A Rare Case 一例由微球菌引起的晚期假体二尖瓣感染性心内膜炎经抗生素治疗完全恢复的罕见病例

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-09-30 DOI: 10.20473/ccj.v3i2.2022.112-118

Imam Mahbub Zam Zami, Agus Subagjo

{"title":"A Late Prosthetic Mitral Valve Infective Endocarditis Caused by Micrococcus spp. that Fully Recovered by Antibiotics Treatment : A Rare Case","authors":"Imam Mahbub Zam Zami, Agus Subagjo","doi":"10.20473/ccj.v3i2.2022.112-118","DOIUrl":"https://doi.org/10.20473/ccj.v3i2.2022.112-118","url":null,"abstract":"Prosthetic valve endocarditis is the most severe form endocarditis with prevalence of 5.7% at 5 years and mortality with medical treatment is 26%-75%. Case Summary: Male, 46 years old, with mechanic mitral prosthetic valve >5 years, hemiparesis sinistra due to embolic stroke >4 weeks prior, was suffering from persistent fever >38,5⁰ for 2 weeks without heart failure. Three separate blood cultures came positive with Micrococcus spp. and Osler’s node was noticed. Echocardiography shown 1.0 cm x 0.9 cm vegetation at mitral prosthetic valve without paravalvular leakage. Patient was assessed as late mitral PVE. Discussion: Gentamycin, Levofloxacin, and Erythromycin were given based on susceptibility test continued by Meropenem as therapy of urinary tract infection based on susceptibility test after second blood culture result was negative. The patient underwent 42 weeks of antibiotics course. The patient was discharged with good condition, no signs and symptoms of infection or heart failure, blood test was within normal limit, no vegetations with prosthetic mitral valve functioned normally. This case shows that late PVE caused by Micrococcus spp. can be treated by 42 weeks course of antibiotics according to microbial susceptibility test.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131674078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Coronary Thrombosis Case in Female Patient with COVID-19 Confirmed Case: Coincidence or Complication? 女性新冠肺炎确诊病例冠状动脉血栓形成:巧合还是并发症?

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-09-30 DOI: 10.20473/ccj.v3i2.2022.129-133

Yosua Hendriko Manurung, Yusuf Galenta

{"title":"Coronary Thrombosis Case in Female Patient with COVID-19 Confirmed Case: Coincidence or Complication?","authors":"Yosua Hendriko Manurung, Yusuf Galenta","doi":"10.20473/ccj.v3i2.2022.129-133","DOIUrl":"https://doi.org/10.20473/ccj.v3i2.2022.129-133","url":null,"abstract":"The worldwide health impact of the COVID-19 epidemic has been felt all across the world, mostly due to respiratory issues, but many additional signs such as cardiac manifestations and different thromboembolisms have also been observed. Case Summary. We provide you with a 48-year-old female patient with COVID-19 pneumonia following a severe infection, who developed Unstable Angina due to coronary thrombosis. She has a history of hypertension and obese posture. No diabetes, hypercholesterolemia, or smoking habit had been recorded. And she still has regular menstrual cycle. Around a month prior to being referred to our hospital, this patient has been admitted to ICU of satellite hospital. She was treated with ventilator and discharged around a week before she was admitted to our Emergency Department. She had typical chest pain with ST-segment depression ECG at antero-septal area. PCI was performed and a large thrombosis was found at LAD artery. Discussion: Many studies have showed that COVID-19, through various ways, has developed thromboembolism both in arteries and venous system. The actual process of thrombus development in the coronary arteries is unknown, however, it is thought that pro-inflammatory cytokinesis released by the body, which stimulates the coagulation cascade and prevent fibrinolysis, are the major cause. This condition that leads to hypercoagulable state which eventually makes an increased risk of thromboembolism.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122204607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correlation of Neutrophyl-Lymphocyte Ratio, Vessel Score based on Sullivan Scoring System, and Troponin in Acute Coronary Syndrome Patients 急性冠脉综合征患者中性粒细胞-淋巴细胞比率、基于沙利文评分系统的血管评分与肌钙蛋白的相关性研究

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-09-30 DOI: 10.20473/ccj.v3i2.2022.75-86

Chelssi Gloria Tessari, A. Lefi, Y. Hernaningsih

{"title":"Correlation of Neutrophyl-Lymphocyte Ratio, Vessel Score based on Sullivan Scoring System, and Troponin in Acute Coronary Syndrome Patients","authors":"Chelssi Gloria Tessari, A. Lefi, Y. Hernaningsih","doi":"10.20473/ccj.v3i2.2022.75-86","DOIUrl":"https://doi.org/10.20473/ccj.v3i2.2022.75-86","url":null,"abstract":"Acute Coronary Syndrome (ACS) is one of the highest causes of death globally, with the number of deaths reaching more than 9 million people in 2016. Therefore, a fast and accurate ACS diagnosis is needed. This study aimed to determine the relationship between the neutrophil-lymphocyte ratio, the number of coronary artery lesions evaluated by angiography, and troponin I in ACS patients Material and Methods: This research is an analytic observational with a retrospective cross-sectional design. Sampling was carried out using a total sampling technique and obtained 87 samples that met the inclusion and exclusion criteria for the 2019-2020 period at Dr. Soetomo Regional General Hospital Surabaya. The correlation between the number of coronary artery lesions and the neutrophil-lymphocyte ratio to troponin I levels were respectively analyzed using chi-square and spearman-rho with SPSS ver. 25. Results: The results showed a moderately significant correlation between the neutrophil-lymphocyte ratio and troponin I levels (p =0.003, rs = 0.319). While the correlation analysis between the number of coronary artery lesions and the vessel score on troponin I showed insignificant results (p = 0.525), which means that the number of coronary artery lesions was not correlated with troponin I. Conclusion: This study concludes a significant correlation with moderate correlation between the neutrophil-lymphocyte ratio and troponin I. However, there is no significant correlation between the number of coronary artery lesions assessed by the Sullivan and troponin I levels.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"97 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127252061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Role of Aerobic Exercise to Prevent Coronary Artery Disease 有氧运动对预防冠状动脉疾病的作用

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-09-30 DOI: 10.20473/ccj.v3i2.2022.87-93

D. Tinduh, Felisita Maritza Abidanovanty, Nabila Sayyida Fairuz Zen, Fadhilah Rahmaputri

{"title":"The Role of Aerobic Exercise to Prevent Coronary Artery Disease","authors":"D. Tinduh, Felisita Maritza Abidanovanty, Nabila Sayyida Fairuz Zen, Fadhilah Rahmaputri","doi":"10.20473/ccj.v3i2.2022.87-93","DOIUrl":"https://doi.org/10.20473/ccj.v3i2.2022.87-93","url":null,"abstract":"Abstract: Background: Coronary Artery Disease (CAD) is a disorder of heart function caused by blockage or narrowing of the coronary arteries so that there is an insufficiency of blood and oxygen flow to the myocardium and becomes the leading cause of death in the world. CAD is one of the causes of the decline in the quality of life of a human being. Methods: This study used a literature review method using 11 scientific articles as online data sources which were then further analyzed. Result and Discussion: Exercise is a recommended therapy as half of the pharmacotherapy. Moderate intensity exercise of 150 minutes per week and vigorous-intensity of more than 75 minutes per week greatly help CR also provide significant benefits when started within 15 days of cardiovascular symptoms appearing. Conclussion: CAD causes the most deaths in the world. From various scientific articles that have been analyzed, exercise, especially aerobic exercise, has been shown to have a good impact on people with CAD that affect lipid metabolism, heart remodeling, insulin resistance, and endothelial function.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132679313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Successful Typical AVNRT Ablation 成功的典型AVNRT消融

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-09-30 DOI: 10.20473/ccj.v3i2.2022.119-128

Angela Bety Ratnasari, B. Dharmadjati

{"title":"Successful Typical AVNRT Ablation","authors":"Angela Bety Ratnasari, B. Dharmadjati","doi":"10.20473/ccj.v3i2.2022.119-128","DOIUrl":"https://doi.org/10.20473/ccj.v3i2.2022.119-128","url":null,"abstract":"AVNRT is the most common regular arrhythmia in humans, and therefore the most commonly encountered during ablation attempts for regular tachycardias. Case Summary: We present a 41-year-old female patient with chest palpitations in the last 10 years, but prior to hospitalization felt heavy sensation on her chest and hospitalized due to heavy chest palpitations and documented SVT. She had no history of hypertension, diabetes mellitus, coronary heart conditions, or stroke. Physical examination showed fair general condition with GCS E4V5M6, blood pressure 130/80, pulse rate 96x / minute, breath rate 18 x / minute and saturation of 99%. Physical examinations are within normal limits. Discussion: Catheter ablation for AVNRT is the current treatment of choice in symptomatic patients. It reduces arrhythmia-related hospitalizations and costs, and substantially improves quality of life. Catheter ablation approaches aimed at the fast pathway have been abandoned; slow pathway ablation, using a combined anatomical and mapping approach, is now the method of choice. This approach offers a success rate of 95 %, has a recurrence rate of approximately 1.3 – 4.0 %, and has been associated with a low risk of atrioventricular (AV) block.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"210 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123332888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ventricular Septal Rupture (VSR) in Post-Acute Anterior Myocardial Infarction Patients : A Case Series 急性前路心肌梗死后患者室间隔破裂(VSR):一个病例系列

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-09-30 DOI: 10.20473/ccj.v3i2.2022.100-111

Ken Christian Kawilarang, I. Hermawan, Febryanti Hartono

{"title":"Ventricular Septal Rupture (VSR) in Post-Acute Anterior Myocardial Infarction Patients : A Case Series","authors":"Ken Christian Kawilarang, I. Hermawan, Febryanti Hartono","doi":"10.20473/ccj.v3i2.2022.100-111","DOIUrl":"https://doi.org/10.20473/ccj.v3i2.2022.100-111","url":null,"abstract":"Case Summary: We present 2 cases of post-STEMI VSR. They had anterior AMI without reperfusion therapy because of patient delay and limited resources. Thereafter apical VSR occurs on 5th day. VSR was suspected because of sudden hemodynamic deterioration and new holosystolic murmur (Grade III/VI) at left parasternal line of fourth-fifth ICS. Then it was confirmed by echocardiography. Both patients underwent hemodynamic stabilization while waiting for surgical therapy. Unfortunately, they deceased because of cardiogenic shock accompanied by other comorbidities. Discussion: VSR causes shunt from left to the right ventricle, which overloads the RV, leading to cardiogenic shock. The peak incidence of VSR in the first 24 hours or 3-5 days post-AMI. This fits both of our cases. VSR occurs in total coronary occlusion, which then causes coagulation necrosis in the ischemic area, characterized by neutrophils that trigger apoptosis and lytic enzymes, so that septum becomes thin, brittle then ruptures. VSR is most common in anterior AMI and the defect is at apical septum, as in our patients. Definitive therapy for VSR is surgical closure, but the best timing is still under debate. This article is expected to make us more aware of post-AMI VSR, so we can quickly diagnose and promptly treat the patients with multidisciplinary approach. This is very important to optimize patient’s outcomes even in limited resources area.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114610740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Fistula Coronary and Coronary Steal Syndrome: A Case Report 冠状动脉瘘和冠状动脉瘘综合征1例报告

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-09-30 DOI: 10.20473/ccj.v3i2.2022.94-99

S. Handari, Puspa Lestari

引用次数: 0

Dapagliflozin Use in Heart Failure with Reduced Ejection Fraction Accompanied by Type 2 Diabetes Mellitus: A Systematic Review 达格列净在心力衰竭伴射血分数降低并2型糖尿病患者中的应用:一项系统综述

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-05-09 DOI: 10.20473/ccj.v3i1.2022.60-74

Sinta Dwi Juniar, M. Y. Alsagaff, Pudji Lestari, B. Pikir

{"title":"Dapagliflozin Use in Heart Failure with Reduced Ejection Fraction Accompanied by Type 2 Diabetes Mellitus: A Systematic Review","authors":"Sinta Dwi Juniar, M. Y. Alsagaff, Pudji Lestari, B. Pikir","doi":"10.20473/ccj.v3i1.2022.60-74","DOIUrl":"https://doi.org/10.20473/ccj.v3i1.2022.60-74","url":null,"abstract":"Abstract: Heart failure patients with reduced ejection fraction (HFrEF) respond well to pharmacological therapy and show a better prognosis. Heart failure patients with reduced ejection fraction and type 2 diabetes who were given SGLT-2 inhibitor therapy showed a strong and consistent reduction in the risk of death and hospitalization. The therapy that has recently begun to be investigated for its benefits for heart failure from the SGLT-2 inhibitor class is Dapagliflozin. The systematic review aims to analyze the effect of Dapagliflozin on the prognosis of HFrEF patients with type 2 diabetes mellitus. Material and Methods: The literature was searched from e-database PubMed, ScienceDirect, and ClinicalTrial.gov. Quality assessment was done using the Critical Appraisal Skills Program (CASP) Randomized Controlled Trial Standard Checklist. Results: A total of 22,167 patients from 4 RCTs eligible studies were included. The analysis results of all of the included studies indicate that Dapagliflozin affected the patient's prognosis. Two studies discuss mortality and hospitalization, and two studies discuss symptoms, functional status, and Quality of Life (QoL). Conclusion: Dapagliflozin can improve the prognosis of HFrEF patients with type 2 DM. The improved prognosis includes reduced mortality, reduced hospitalizations by minimizing disease worsening, reducing symptoms, improving functional status and QoL.Keyword: SGLT 2 inhibitor; Dapagliflozin; Prognosis; Cardiovascular disease; Diabetes.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127478115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correlation between Age and Defect Size with Increased Pulmonary Arterial Pressure in Adult Atrial Septal Defect (ASD) Patients at Cardiology and Vascular Medicine Department dr. Seotomo Public Hospital Surabaya 2019-2021 2019-2021年泗水Seotomo公立医院心血管内科成人房间隔缺损(ASD)患者年龄、缺损大小与肺动脉压升高的相关性

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-04-06 DOI: 10.20473/ccj.v3i1.2022.15-21

Astrid Aulia Artiono Puteri, Y. Oktaviono, A. Prasmono

{"title":"Correlation between Age and Defect Size with Increased Pulmonary Arterial Pressure in Adult Atrial Septal Defect (ASD) Patients at Cardiology and Vascular Medicine Department dr. Seotomo Public Hospital Surabaya 2019-2021","authors":"Astrid Aulia Artiono Puteri, Y. Oktaviono, A. Prasmono","doi":"10.20473/ccj.v3i1.2022.15-21","DOIUrl":"https://doi.org/10.20473/ccj.v3i1.2022.15-21","url":null,"abstract":"Abstract: Atrial Septal Defect (ASD) is one of the three most common types of congenital heart disease in the world. Pulmonary arterial hypertension (PAH) is a complication that can be found in patients with secundum type of ASD. There is no research that shows the relationship between patient’s age and defect size with increased pulmonary artery pressure in secundum type of ASD patients in Indonesia, so further research needs to be done. Material and Methods: This study is a retrospective study using an observational analytical research design with cross sectionalapproach. The data from this study were taken from the medical records of ASD patients at the Cardiology and Vascular Department of Dr. Soetomo Public Hospital Surabaya. Results: Sex distribution of patients with secundum ASD was dominated by female patients with a total of 53 people (81.5%), the age distribution of patients was dominated by patients in the age group of 20-24 years as many as 18 people (27.7%). The most common comorbidities in adult secundum ASD patients were hypertension (3.08%) and minor CAD (3.08%). The mean diameter of the secundum ASD defect was 28.03±9.57 mm, and the data for the smallest defect diameter was 4 mm and the largest was 48 mm. Complications of increased PA pressure were dominated by 20 patients with mild PH (30.8%) and the mean mPAP pressure was 39.87±19.03. There were no patients with Eisenmenger syndrome.Conclusion: There was no correlation between patient age and inter-atrial septal diameter with mPAP pressure.","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117269566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Identification of The Effect of Hyberbaric Oxygen Therapy (HBOT) on Blood Pressure Lowering Effects in Hypertension Patients 高压氧治疗(HBOT)对高血压患者降压效果的影响

Cardiovascular and Cardiometabolic Journal (CCJ) Pub Date : 2022-04-06 DOI: 10.20473/ccj.v3i1.2022.52-59

Karindra Amadea Susetiyo, Agus Subagjo, Primadita Syahbani, Iqlima Rahmawati, Ikhsanuddin Qothi

{"title":"Identification of The Effect of Hyberbaric Oxygen Therapy (HBOT) on Blood Pressure Lowering Effects in Hypertension Patients","authors":"Karindra Amadea Susetiyo, Agus Subagjo, Primadita Syahbani, Iqlima Rahmawati, Ikhsanuddin Qothi","doi":"10.20473/ccj.v3i1.2022.52-59","DOIUrl":"https://doi.org/10.20473/ccj.v3i1.2022.52-59","url":null,"abstract":"Hypertension is a leading cause of death worldwide including in Indonesia. The World Health Organization (WHO) estimates that currently the global prevalence of hypertension is 22% (WHO, 2019). In 2018 the prevalence of hypertension in Indonesia reached 34,11% (Riskesdas, 2018). Every year, it is estimated that 10.4 million deaths are caused by hypertension (Unger et al., 2020). Hyperbaric Oxygen Therapy (HBOT) is a therapy with pure oxygen concentration (100%) in a high pressure room (Ortega et al., 2021). In previous studies it was found that HBOT improves the effects of vasodilation (Mihaljevic et al., 2018). However, other studies mention different results. It was found that HBOT initiates vasoconstriction and increases systemic vascular resistance. This causes a decrease in nitrite oxide (NO) production and increase NO oxidation (Goyal et al., 2021). Apart from a variety of different study results, the use of HBOT has indeed been widely studied even though it has not found a clear meeting point on the effects of blood pressure reduction on hypertension patients. Therefore, the author aims to find out more clearly the mechanism and benefits of hyperbaric oxygen therapy against decreased blood pressure in hypertension patients. ","PeriodicalId":371103,"journal":{"name":"Cardiovascular and Cardiometabolic Journal (CCJ)","volume":"184 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131468883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0